HOME >> MEDICINE >> NEWS
Takeda submits new drug application for extended-release type 2 diabetes medication, ACTOplus met

LINCOLNSHIRE, Ill. Takeda Global Research & Development Center (TGR&D) today announced that the company has submitted a New Drug Application (NDA) for an extended-release version of the combination medication ACTOplus met TM (pioglitazone HCl and metformin HCl) to the United States Food and Drug Administration (FDA) for the treatment of type 2 diabetes. This new formulation (ACTOplus met XR) would allow for once-daily dosing, while ACTOplus met (immediate release) is already available, being marketed by Takeda Pharmaceuticals North America, Inc.

ACTOplus met is an oral medication that combines ACTOS (pioglitazone HCl), which directly targets insulin resistance a condition in which the body does not efficiently use the insulin it produces with metformin, which acts primarily by reducing the amount of glucose produced by the liver. These medications work in combination to help patients with type 2 diabetes manage their blood glucose levels.

The NDA submission represents yet another milestone for Takeda, following the FDA approval of ROZEREMTM(ramelteon).

"We are certainly proud of this NDA submission, and the ACTOS portfolio of products," said John Yates, M.D., president of TGR&D. "Not all patients are alike, especially in diabetes, and the addition of this new product would provide patients and their physicians with more options and greater flexibility, while continuing to provide the benefits of treatment with ACTOS." Extended-release metformin, one of the active ingredients in ACTOplus met XR, was developed by Andrx Corporation. Takeda Pharmaceutical Company Limited signed an agreement with Andrx Corporation covering extended-release metformin in December 2003.


'"/>


3-Apr-2006


Page: 1

Related medicine news :

1. Takeda responds to the FDA advisory committee recommendation
2. Takeda submits new drug application for combination type 2 diabetes medication
3. Sucampo Pharmaceuticals submits supplemental new drug application for Lubiprostone to treat IBS-C
4. Sucampo submits new drug application for lubiprostone
5. Brightening prospects of using fluorescent nanotubes in medical applications
6. Panbio files first patent application for Homogenous Assay Technology
7. LOral accepting applications for 2007 USA fellowships for Women in Science
8. NIH wrongly blamed for reduced success rate of grant applications
9. Magnet lab researcher exploring science behind commercial applications of liquid helium
10. Dalai Lama, top scientists to discuss science & clinical applications of meditation
11. Mechanism controlling DNA damage response has potential novel medical applications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... 08, 2019 , ... U.S. Oral Surgery Management (USOSM) – ... oral and maxillofacial surgeons – has formed a new partnership with Oral and ... near Knoxville, Tennessee. The partnership is USOSM’s first in the state of Tennessee. ...
(Date:10/8/2019)... ... ... Grove Fertility (SGF) , a pioneer in offering an IVF treatment refund guarantee, known as ... eggs take home a baby, and more than 85% of participants who use a donor ... years ago by SGF Co-founder, Michael J. Levy, M.D ., specifically to help patients ...
(Date:10/8/2019)... ... October 08, 2019 , ... Continuing its leading research ... showing that Care4U™ 2’-FL, a DuPont product, beneficially changes microbiota composition and the ... elicited to microbiota and metabolite composition by 2’-FL were between the responses elicited ...
(Date:10/8/2019)... OAK BROOK, Ill. (PRWEB) , ... October 08, ... ... management system to achieve compliance with the newest electronic prescribing standards. The newest ... into effect Jan. 1, 2020 — creating pressure for technology companies to get ...
(Date:10/8/2019)... ... October 08, 2019 , ... Professional Services Plans®, a leading ... of Brenda Thomas, an industry professional with expertise in Dental Professional Liability insurance ... Plans dental team at Brown & Brown Insurance, with a focus on the ...
Breaking Medicine News(10 mins):
(Date:10/11/2019)... ... ... New York fitness studios have teamed up to create the first ever Hell’s Kitchen Sweat ... variety of the top group exercise classes offered on the West Side of Manhattan. Held ... 57th St., the Hell’s Kitchen Sweat Crawl will feature 25-minute workout classes at Club ...
(Date:10/11/2019)... ... October 11, 2019 , ... On ... national resource — held the grand opening for Long Island’s first-of-a-kind boutique CBD ... a thoughtfully curated lineup of CBD wellness products tailored to health-conscious consumers. , ...
(Date:10/10/2019)... ... 10, 2019 , ... Global Composer & Activist Nenad Bach ... Tennis Championships, October 11th – 13th,  , The debilitating effects of Parkinson’s disease left ... to find a way to combat the disease. A friend invited him to ...
Breaking Medicine Technology:
Cached News: